Rare cancer patient has to pay £5,000 every three weeks for treatment not approved in UK

Julie Woodington, 56, from, Bristol, said she is going to have to sell her home to fund the treatment for her lung cancer, which is approved in the EU and the US - but not in the UK

Related Keywords

Bristol ,City Of ,United Kingdom ,United States ,France ,Germany ,Kingswood ,South Gloucestershire ,Britain ,Chris Skidmore ,Julie Woodington ,Gillian Leng ,Daiichi Sankyo ,Ben Woodington ,Astrazeneca ,National Institute For Health ,Bristol Royal ,National Institute ,Care Excellence ,Will Quince ,Secondary Care ,Chief Executive ,Nhs ,Astrazeneca Plc ,Nice ,European Union ,Hospitals ,Breast Cancer ,Lung Cancer ,Cancer ,